URSO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urso, and when can generic versions of Urso launch?
Urso is a drug marketed by Abbvie, Abhai Llc, Amneal Pharms Co, Aurobindo Pharma Ltd, Chartwell Rx, Epic Pharma, Hibrow Hlthcare, Impax Labs Inc, Lannett Co Inc, Lgm Pharma, Quagen, Rising, Rk Pharma, Strides Pharma, Teva Pharms, Zydus Lifesciences, Epic Pharma Llc, Glenmark Pharms Ltd, Ph Health, and Teva Pharms Usa. and is included in twenty-three NDAs.
The generic ingredient in URSO is ursodiol. There are eight drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urso
A generic version of URSO was approved as ursodiol by EPIC PHARMA on March 14th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for URSO?
- What are the global sales for URSO?
- What is Average Wholesale Price for URSO?
Summary for URSO
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 23 |
| Drug Prices: | Drug price information for URSO |
| DailyMed Link: | URSO at DailyMed |
US Patents and Regulatory Information for URSO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | URSODIOL | ursodiol | TABLET;ORAL | 211145-001 | Oct 30, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Strides Pharma | URSODIOL | ursodiol | TABLET;ORAL | 213504-001 | Aug 20, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | URSODIOL | ursodiol | TABLET;ORAL | 211145-002 | Oct 30, 2018 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Strides Pharma | URSODIOL | ursodiol | TABLET;ORAL | 213504-002 | Aug 20, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Abbvie | URSO 250 | ursodiol | TABLET;ORAL | 020675-001 | Dec 10, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Pharms | URSODIOL | ursodiol | CAPSULE;ORAL | 075592-001 | May 25, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs Inc | URSODIOL | ursodiol | TABLET;ORAL | 200826-001 | Dec 23, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
